Roles of PINK1, mTORC2, and mitochondria in preserving brain tumor-forming stem cells in a noncanonical Notch signaling pathway
- Kyu-Sun Lee1,2,8,
- Zhihao Wu1,8,
- Yan Song1,3,4,
- Siddhartha S. Mitra5,6,
- Abdullah H. Feroze5,6,7,
- Samuel H. Cheshier5,6,7 and
- Bingwei Lu1,9
- 1Department of Pathology, Stanford University School of Medicine, Stanford, California 94305, USA;
- 2BioNanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 305-806, Korea;
- 3School of Life Sciences,
- 4Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100871, China;
- 5Institute of Stem Cell Biology and Regenerative Medicine,
- 6Stanford Ludwig Center for Cancer Stem Cell Research and Medicine,
- 7Department of Neurosurgery, Stanford University School of Medicine, Stanford, California 94305, USA
-
↵8 These authors contributed equally to this work.
Abstract
The self-renewal versus differentiation choice of Drosophila and mammalian neural stem cells (NSCs) requires Notch (N) signaling. How N regulates NSC behavior is not well understood. Here we show that canonical N signaling cooperates with a noncanonical N signaling pathway to mediate N-directed NSC regulation. In the noncanonical pathway, N interacts with PTEN-induced kinase 1 (PINK1) to influence mitochondrial function, activating mechanistic target of rapamycin complex 2 (mTORC2)/AKT signaling. Importantly, attenuating noncanonical N signaling preferentially impaired the maintenance of Drosophila and human cancer stem cell-like tumor-forming cells. Our results emphasize the importance of mitochondria to N and NSC biology, with important implications for diseases associated with aberrant N signaling.
Keywords
Footnotes
-
↵9 Corresponding author
E-mail bingwei{at}stanford.edu
-
Supplemental material is available for this article.
-
Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.225169.113.
- Received June 22, 2013.
- Accepted November 6, 2013.
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.










